NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients.
Clinical trial NCT04861181 · TERMINATED
Trial details
- NCT number
- NCT04861181
- Sponsor
- Hospices Civils de Lyon
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2025-04-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.